Pharmacologic treatment of attention-deficit/hyperactivity disorder: Efficacy, safety and mechanisms of action

Medicine and Dentistry

• Attention Deficit Disorder 100%
• Therapeutic Procedure 60%
• Mechanism of Action 60%
• Side Effect 40%
• Medication 40%
• Cardiovascular System 20%
• Anterior Cingulate 20%
• Cingulate Cortex 20%
• Drug Therapy 20%
• Catecholamine 20%
• Analeptic 20%
• Rating Scale 20%
• Atomoxetine 20%
• Psychosis 20%
• Positron Emission Tomography 20%
• Event-Related Potential 20%
• Functional Magnetic Resonance Imaging 20%
• Insomnia 20%
• Headache 20%
• Loss of Appetite 20%
• Child 20%
• Neuroimaging 20%
• Adult 20%
• Adolescent 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Attention Deficit Disorder 100%
• Side Effect 40%
• Catecholamine 20%
• Psychosis 20%
• Stimulant 20%
• Sudden Death 20%
• Headache 20%
• Insomnia 20%
• Atomoxetine 20%
• Loss of Appetite 20%

Neuroscience

• Attention Deficit Hyperactivity Disorder 100%
• Anterior Cingulate Cortex 20%
• Catecholamine 20%
• Event-Related Potential 20%
• Psychosis 20%
• Positron Emission Tomography 20%
• Functional Magnetic Resonance Imaging 20%
• Atomoxetine 20%
• Insomnia 20%
• Appetite 20%